Tamboran Resources (NYSE: TBN) closes entitlement, underwritten and direct equity deals
Rhea-AI Filing Summary
Tamboran Resources Corporation completed several equity financings. The company closed an accelerated non-renounceable institutional entitlement offer to eligible non-U.S. holders, issuing 148,308,400 CHESS Depositary Interests, each representing 1/200th of a share of common stock, underpinned by 741,542 shares. This raised aggregate proceeds of A$37.1 million at A$0.25 per CDI under Regulation S.
The company also completed the sale of 443,491 additional common shares under a previously announced underwritten offering, after underwriters exercised their option in full, generating additional net proceeds of $14.7 million. In a registered direct institutional entitlement offering priced at $35.00 per share, Tamboran issued 916,412 shares, with a remaining portion of approximately 96,698 shares expected to close on or about April 15, 2026, subject to customary conditions.
Positive
- None.
Negative
- None.
Insights
Tamboran raises multi-currency equity capital through three coordinated offerings.
Tamboran Resources Corporation executed an Australian entitlement offer, an underwritten U.S. common stock offering, and a registered direct institutional entitlement offering. Together, these transactions add new equity capital in both Australian dollars and U.S. dollars, using different structures for distinct investor bases.
The accelerated non-renounceable institutional entitlement offer raised A$37.1 million via CHESS Depositary Interests, targeting existing shareholders in specified non-U.S. jurisdictions under Regulation S. The underwriters’ full exercise of the 443,491-share option generated additional net proceeds of $14.7 million, signaling completion of the upsized underwritten component.
The registered direct institutional entitlement offering priced at $35.00 per share closed initially on April 14, 2026 for 916,412 shares, with about 96,698 further shares expected to close on or about April 15, 2026 subject to customary closing conditions. Overall impact on valuation and dilution depends on the company’s subsequent deployment of capital and future disclosures.